the aid library

LIST OPTIONS

Filter

2482

Sort by:

Direction:

Download (103)

View PDF (143)

Handbook on HIV and Human Rights for National Human Rights Institutions

UNAIDS; Joint United Nations Programme on HIVAIDS and Office of the United Nations High Commissioner for Human Rights (2007) C2

Download (97)

View PDF (689)

An Independent Review of World Bank Support for Capacity Building in Africa: The Case of Benin

Corporate Evaluation and Methods Operations Evaluation Department World Bank (2005) C2

Relevance and effectiveness of World Bank support for public sector capacity building in Sub-Saharan Africa from 1995 to 2004. Benin is part of a six country case study.

Download (1179)

View PDF (1616)

Elargir la Pratique Pharmaceutique - Recentrer les soins sur les patients.

Wiedenmayer, K. et al. organisation mondiale de la Santé (OMS), Fédération internationale pharmaceutique (FIP) (2006) CC

French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants ... more

Download (441)

View PDF (795)

Antimicrobial Stewardship Program Guideline (India)
recommended

Balaji, V., P. Rupali, K. Walia, et al. Indian Council of Medical Research (2018) C2

Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o... more

Download (700)

View PDF (871)

Manuel de normes de prise en charge clinique e therapeutiques des adolescents e adultes vivant avec le VIH/SIDA

Programme National de Lutte contre les ISTVIH (2010) CC

Download (549)

View PDF (951)

Nepal: Saarc Guidelines for Partnership with School in Prevention and Control of Tuberculosis and HIV/AIDS

SAARC Tuberculosis and HIVAIDS Centre (2006) C1

Download (1050)

View PDF (559)

Zambia Essential Medicines List (ZEML) 05
recommended

Ministry of Health, Zambia (2020) C1

2020 Version

Download (231)

View PDF (268)

Stratégie de Coopération de l’OMS avec les pays, 2008-2013, République de Madagascar

Organisation mondiale de la Santé (WHO), Bureau Régional de l'Afrique (2009) C_WHO

Download (1288)

View PDF (5203)

Précautions standard pour contrôler les infections à l'hôpital

Organisation Mondiale de la Santé OMS (1998)

Download (428)

View PDF (744)

POCKET GUIDE ON DISIBILITY EQUITY AN EMPOWERMENT TOOL

Disabled People South Africa (DPSA) DPSA PALIMENTRY OFFICE (2001) C2

In support of the African decade of disabled persons | 1st January 199 - 31st of December 2009

Download (187)

View PDF (267)

Clinical quality and patient safety in child and adolescent mental health

Fung; D.; C. M. Chern; T. Z. Ting Fang IACAPAP (2019) C2

Miscellaneous Chapter J.8

Download (1225)

View PDF (3715)

Flambées de choléra
recommended

Organisation mondiale de la Santé (2004) C_WHO

Évaluation des mesures mises en oeuvre en cas de flambées et amélioration de la préparation

Download (87)

View PDF (121)

Questions prioritaires de recherche sur la co-infection tuberculose/VIH dans les pays prévalents pour le VIH et disposant de ressources limitées

H, Getahun; R. Granich; C. Lienhardt; et al. Organisation Mondiale de la Santé (TBHIV Working Group) (2010) C_WHO

Stop TB Partnership

Download (109)

View PDF (161)

Children affected by HIV/AIDS in South Africa

R. Smart; HIVAIDS Consultant Save the Children (UK) South Africa Programme; The Department of Social Development (2003) C2

A Rapid Appraisal of Priorities, Policies and Practices

Download (121)

View PDF (187)

Considerations and Principles for Shielding People at High Risk of Severe Outcomes from COVID-19

Social Science in Humanitarian Action (2020) CC

This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline... more

Download (100)

View PDF (112)

The impact of the COVID-19 pandemic on child health and the provision of Care in Paediatric Emergency Departments

Conlon C., T. McDonnell, M. Barrett, et al. BMC (2021) CC

The COVID-19 pandemic and subsequent public health guidance to reduce the spread of the diseasehave wide-reaching implications for children’s health and wellbeing. Furthermore, paediatric emergency departments(EDs) have rapidly adapted provision of care in response to the pandemic. This qualitativ... more

Download (56)

View PDF (828)

Tuberculosis services disrupted by war in Ukraine

Holt, E. (2022) C2

the Lancet Infectious Diseases Published online March 22, 2022 https://daoi.org/10.1016/S1473-3099(22)00214-6

Download (81)

View PDF (445)

Health beliefs and health seeking behavior towards lymphatic filariasis morbidity management and disability prevention services in Luangwa District, Zambia: Community and provider perspectives

Maritim, P., A. Silumbwe, J.M. Zulu, et al. (2021) C2

Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute... more

Download (25)

View PDF (18)

Associations of the built environment with type 2 diabetes in Asia: a systematic review

Aarthi, G.R.; Begum, T. S. M.; Al Moosawi, S.; et al. BMJ Open (2023) CC2

Objectives Our study aimed to systematically review the literature and synthesise findings on potential associations of built environment characteristics with type 2 diabetes (T2D) in Asia.

Download (6)

View PDF (5)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Antimicrobial Stewardship Program Guideline (India) recommended

Zambia Essential Medicines List (ZEML) 05 recommended

Flambées de choléra recommended

Antimicrobial Stewardship Program Guideline (India)
recommended

Zambia Essential Medicines List (ZEML) 05
recommended

Flambées de choléra
recommended